Patents Represented by Attorney Nora Hackett
  • Patent number: 5427932
    Abstract: A primer directed DNA amplification method to isolate efficiently chromosome-specific repeated DNA wherein degenerate oligonucleotide primers are used is disclosed. The probes produced are a heterogeneous mixture that can be used with blocking DNA as a chromosome-specific staining reagent, and/or the elements of the mixture can be screened for high specificity, size and/or high degree of repetition among other parameters. The degenerate primers are sets of primers that vary in sequence but are substantially complementary to highly repeated nucleic acid sequences, preferably clustered within the template DNA, for example, pericentromeric alpha satellite repeat sequences. The template DNA is preferably chromosome-specific. Exemplary primers ard probes are disclosed. The probes of this invention can be used to determine the number of chromosomes of a specific type in metaphase spreads, in germ line and/or somatic cell interphase nuclei, micronuclei and/or in tissue sections.
    Type: Grant
    Filed: March 26, 1992
    Date of Patent: June 27, 1995
    Assignee: Reagents of the University of California
    Inventors: Heinz-Ulrich G. Weier, Joe W. Gray
  • Patent number: 5242647
    Abstract: The invention describes a method for making monolithic castings of transparent silica aerogel with densities in the range from 0.001 g/cm.sup.3 to 0.6 g/cm.sup.3. Various shapes of aerogels are cast in flexible polymer molds which facilitate removal and eliminate irregular surfaces. Mold dimensions are preselected to account for shrinkage of alcogel which occurs during the drying step of supercritical extraction of solvent.
    Type: Grant
    Filed: July 30, 1991
    Date of Patent: September 7, 1993
    Assignee: Regents of The University of California
    Inventor: John F. Poco
  • Patent number: 5108900
    Abstract: Methods are described for making specific monoclonal antibodies which may be used in a sensitive immunoassay for detection of synthetic pyrethroids in foods and environmental samples. Appropriate sample preparation and enzyme amplification of the immunoassay for this widely-used class of pesticides permits detection at low levels in laboratory and field tested samples.
    Type: Grant
    Filed: March 6, 1989
    Date of Patent: April 28, 1992
    Assignee: Regents of the University of California
    Inventors: Larry H. Stanker, Martin Vanderlaan, Bruce E. Watkins, Jeanette M. Van Emon, Carolyn L. Bigbee
  • Patent number: 5053336
    Abstract: Monoclonal antibodies are described which have specific affinities for halogenated nucleoside analogs and are preferentially selective for one particular halogen. Such antibodies, when incorporated into immunochemical reagents, may be used to identify and independently quantify the cell division character of more than one population or subpopulation in flow cytometric measurements. Independent assessment of division activity in cell sub-populations facilitates selection of appropriate time and dose for administration of anti-proliferative agents. The hybridomas which secrete halogen selective antibodies and the method of making them are described.
    Type: Grant
    Filed: July 17, 1989
    Date of Patent: October 1, 1991
    Assignee: Regents of the University of California
    Inventors: Martin Vanderlaan, Bruce E. Watkins, Larry H. Stanker
  • Patent number: 5001051
    Abstract: A method and apparatus are disclosed for the in vivo and in vitro detection and measurement of dose critical levels of DNA-binding anti-cancer drug levels in biological fluids. The apparatus comprises a laser based fiber optic sensor (optrode) which utilizes the secondary interactions between the drug and an intercalating fluorochrome bound to a probe DNA, which in turn is attached to the fiber tip at one end thereof. The other end of the optical fiber is attached to an illumination source, detector and recorder. The fluorescence intensity is measured as a function of the drug concentration and its binding constant to the probe DNA.Anticancer drugs which lend themselves to analysis by the use of the method and the optrode of the present invention include doxorubicin, daunorubicin, carminomycin, aclacinomycin, chlorambucil, cyclophosphamide, methotrexate, 5-uracil, arabinosyl cytosine, mitomycin, cis-platinum 11 diamine dichloride procarbazine, vinblastine vincristine and the like.
    Type: Grant
    Filed: December 12, 1986
    Date of Patent: March 19, 1991
    Assignee: Regents of the University of California
    Inventors: Holly H. Miller, Tomas B. Hirschfeld, deceased